478 related articles for article (PubMed ID: 8302017)
1. The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage.
Greenwood J; Howes R; Lightman S
Lab Invest; 1994 Jan; 70(1):39-52. PubMed ID: 8302017
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural analysis of interleukin-1 beta-induced leukocyte recruitment to the rat retina.
Bamforth SD; Lightman SL; Greenwood J
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):25-35. PubMed ID: 9008627
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural pathology of experimental autoimmune uveitis. Quantitative evidence of activation and possible high endothelial venule-like changes in retinal vascular endothelium.
McMenamin PG; Forrester JV; Steptoe RJ; Dua HS
Lab Invest; 1992 Jul; 67(1):42-55. PubMed ID: 1625447
[TBL] [Abstract][Full Text] [Related]
4. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis.
Prendergast RA; Iliff CE; Coskuncan NM; Caspi RR; Sartani G; Tarrant TK; Lutty GA; McLeod DS
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):754-62. PubMed ID: 9538882
[TBL] [Abstract][Full Text] [Related]
5. Effect of lymphocytic infiltration on the blood-retinal barrier in experimental autoimmune uveoretinitis.
Lightman S; Greenwood J
Clin Exp Immunol; 1992 Jun; 88(3):473-7. PubMed ID: 1606733
[TBL] [Abstract][Full Text] [Related]
6. Role of retinal pigment epithelium in the development of experimental autoimmune uveitis.
Konda BR; Pararajasegaram G; Wu GS; Stanforth D; Rao NA
Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):40-7. PubMed ID: 8300362
[TBL] [Abstract][Full Text] [Related]
7. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis.
Butler TL; McMenamin PG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2195-210. PubMed ID: 8843906
[TBL] [Abstract][Full Text] [Related]
8. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules.
Xu H; Forrester JV; Liversidge J; Crane IJ
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):226-34. PubMed ID: 12506079
[TBL] [Abstract][Full Text] [Related]
10. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown.
Luna JD; Chan CC; Derevjanik NL; Mahlow J; Chiu C; Peng B; Tobe T; Campochiaro PA; Vinores SA
J Neurosci Res; 1997 Aug; 49(3):268-80. PubMed ID: 9260738
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine.
Bamforth SD; Lightman SL; Greenwood J
Am J Pathol; 1997 Jan; 150(1):329-40. PubMed ID: 9006348
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha.
Claudio L; Martiney JA; Brosnan CF
Lab Invest; 1994 Jun; 70(6):850-61. PubMed ID: 8015289
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood-retina barrier.
Xu H; Dawson R; Crane IJ; Liversidge J
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2487-94. PubMed ID: 15980240
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
Vinores SA; McGehee R; Lee A; Gadegbeku C; Campochiaro PA
J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA
Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
[TBL] [Abstract][Full Text] [Related]
16. Assessment of blood-retinal barrier integrity.
Vinores SA
Histol Histopathol; 1995 Jan; 10(1):141-54. PubMed ID: 7756735
[TBL] [Abstract][Full Text] [Related]
17. Effect of anti-macrophage inflammatory protein-1alpha on leukocyte trafficking and disease progression in experimental autoimmune uveoretinitis.
Crane IJ; Xu H; Manivannan A; McKillop-Smith S; Lamont G; Wallace C; Liversidge J; Sharp PF; Forrester JV
Eur J Immunol; 2003 Feb; 33(2):402-10. PubMed ID: 12645937
[TBL] [Abstract][Full Text] [Related]
18. Experimental autoimmune uveoretinitis. Ultrastructure of chorioretinal lesions induced in guinea pigs by immunization against the outer rods of the bovine retina.
De Kozak Y; FRE ; Usui M; Faure JP
Arch Ophtalmol (Paris); 1976 Mar; 36(3):231-48. PubMed ID: 137707
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructure of blood-retinal barrier permeability in rat phototoxic retinopathy.
Korte GE; Bellhorn RW; Burns MS
Invest Ophthalmol Vis Sci; 1983 Jul; 24(7):962-71. PubMed ID: 6862798
[TBL] [Abstract][Full Text] [Related]
20. The blood-retinal barrier in experimental autoimmune uveoretinitis (EAU): a review.
Greenwood J
Curr Eye Res; 1992; 11 Suppl():25-32. PubMed ID: 1424749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
